Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05215197 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Intracochlear Platelet-rich Fibrin Application in Cochlear Implantation

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Dec 1, 2025 to Dec 1, 2028
    • Study completion date: Dec 20, 2025 to Dec 20, 2028
    v6
  2. Primary completion date: Dec 1, 2024 to Dec 1, 2025
    • Study completion date: Dec 20, 2024 to Dec 20, 2025
    v5
  3. Primary completion date: Dec 1, 2023 to Dec 1, 2024
    • Study completion date: Dec 20, 2023 to Dec 20, 2024
    v4
  4. Primary completion date: Dec 1, 2022 to Dec 1, 2023
    • Study completion date: Dec 20, 2022 to Dec 20, 2023
    v3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Interventions: intracochlear platelet rich fibrin administration (Other) to intracochlear platelet rich fibrin administration (Drug)
    • Site details revised
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Fibrosis due to surgical trauma is a common problem with cochlear implants. Fibrosis limits the effectiveness of implant and increases the power consumption. Our aim in this study is to benefit from the anti-inflammatory effects of autologous platelet-rich fibrin to reducing the fibrotic cascade.
Trial Details
NCT Number NCT05215197
Lead Sponsor Pamukkale University
Conditions
(from sponsor)		 Hearing Loss, Sensorineural
Related terms Hearing Loss, Sensorineural
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov